ライフサイエンスコーパス: blood draw

1 from five cohorts (median age 44-48 years at blood draw).

2 od draws) and 80.4% in Kano State (n = 2,178 blood draws).

3 rial biopsies and a pre-operative peripheral blood draw.

4 time of blood draw, and hours fasting before blood draw.

5 the reduction began as early as 7 hours post-blood draw.

6 l, lung or liver cancer within four years of blood draw.

7 ot vary by adult BMI or menopausal status at blood draw.

8 ge, race, duration of follow-up, and time of blood draw.

9 zed with respect to their volume and site of blood draw.

10 f contamination among the different sites of blood draw.

11 who had fasted for more than 10 hours before blood draw.

12 age, time since initial screen, and year of blood draw.

13 ccording to age, smoking status, and time of blood draw.

14 valent cardiovascular disease, and timing of blood draw.

15 ontrol subjects by age, smoking, and time of blood draw.

16 -period since initial screening, and date of blood draw.

17 r age, smoking, fasting status, and month of blood draw.

18 e and matched by age, sex, race, and date of blood draw.

19 and nondiabetics with an overnight fast for blood draw.

20 detect tuberculosis infection using a single blood draw.

21 patient samples processed immediately after blood draw.

22 articipants (now adults) completed a fasting blood draw.

23 70 patients with different atrial rhythms at blood draw.

24 ancer after enrollment and before the second blood draw.

25 individual controls on age, sex, and date of blood draw.

26 d over 12-, 3-, and 1-month periods prior to blood draw.

27 dairy intake, physical activity, and year of blood draw.

28 inuous sodium and potassium levels without a blood draw.

29 pheral blood mononuclear cells from a single blood draw.

30 opharyngeal RT-PCR (Ct 22.3) concurrent with blood draw.

31 trometry in biological samples from the same blood draw.

32 2020-21 who participated in the surveys and blood draw.

33 samples were collected 65 min after the 0-h blood draw.

34 d for a minimum of 3 years after their first blood draw.

35 e, and a lipid panel via an optional fasting blood draw.

36 the body, the present method requires only a blood draw.

37 xome sequencing coverage than DNA from fresh blood draw.

38 stage and outcome measures from the date of blood draw.

39 mass spectrometry and adjusted for season of blood draw.

40 volumes commonly available from fingerstick blood draw.

41 to each case by age, race, sex, and month of blood draw.

42 able to cooperate with fingerstick or venous blood draw.

43 eminating tumor cell population via a simple blood draw.

44 .6% other), hysterectomy status, and date of blood draw.

45 and interleukin-6 were assayed from baseline blood draws.

46 ntaining [U-(13)C]-labeled SCFAs followed by blood draws.

47 nitive Function questionnaire (FACT-Cog) and blood draws.

48 s were collected during clinically indicated blood draws.

49 were analyzed in 196 patients with multiple blood draws.

50 unoglobulin A between the 6-week and 6-month blood draws.

51 eline and postintervention (9-month) fasting blood draws.

52 ncrease in CTC capture, compared with serial blood draws.

53 mprehensive follow-up schedule with frequent blood draws.

54 s, who underwent standardized interviews and blood draws.

55 le out AMI in 58% of patients without serial blood draws.

56 were matched to the cases by age and date of blood drawing.

57 or age, smoking, fasting status, and date of blood drawing.

58 8 and were free of cardiovascular disease at blood drawing.

59 rmally and without sophisticated reagents or blood drawing.

60 aw (n = 175), and PTSD that persisted beyond blood draw 1 (chronic PTSD; n = 174).

61 ma at either blood draw (n = 175), trauma at blood draw 1 but no PTSD at either draw (n = 175), and P

62 ed RBC specimens and no history of cancer at blood draw (1989-1090 and 1994-1995, respectively).

63 not using exogenous hormones at the time of blood draw (1989-1990).

64 cases diagnosed more than seven years after blood draw, 29 of 618 were associated in genetic analyse

65 2 patients became PCR negative on a repeated blood draw 5 months after initial detection of C pneumon

66 who completed treatment and had a successful blood draw, 61 (92%) had undetectable HCV RNA at treatme

67 atment and the other isolate (R712) was from blood drawn after treatment with daptomycin.

68 50 cases and 314 controls matched on date of blood draw, age at blood draw, and region was used to de

69 .88) but not among women aged >/=40 years at blood draw (all Pheterogeneity </= 0.05).

70 c or psychiatric history completed a fasting blood draw and a brief neuropsychological test battery.

71 Each visit included a blood draw and anxiety evaluation (as measured by the an

72 Blood draw and aqueous sampling of each eye was performe

73 d 377 cases of breast cancer diagnosed after blood draw and before June 2000; two controls were match

74 Average time between blood draw and death was 5.6 years (standard deviation =

75 st for cases with shortest lag times between blood draw and diagnosis (<3 years).

76 cipants with OPC with up to 10 years between blood draw and diagnosis and 5,794 controls.

77 atched per case on age, menopausal status at blood draw and diagnosis, fasting status, and time of da

78 by postmenopausal hormone use, years between blood draw and diagnosis, or after adjustment for estrad

79 rtion who would permit being enrolled in the blood draw and lumbar puncture studies, respectively, we

80 udies that included either a blood draw or a blood draw and lumbar puncture to explore older persons'

81 CTCs can be detected by a simple peripheral blood draw and potentially show global features of tumor

82 f 969 cases of breast cancer diagnosed after blood draw and prior to June 1, 1998, were individually

83 Each visit included a blood draw and psychological evaluation, with clinical a

84 red from each bronchoscopy and corresponding blood draw and subjected to polychromatic flow cytometry

85 = 33.07, male = 19, female = 11) underwent a blood draw and T1-weighted magnetic resonance imaging.

86 n models were further adjusted for season of blood draw and when analyses were restricted to the firs

87 the predictive ability of models requiring a blood draw and/or a voiding cystourethrogram.

88 Recommended procedures for blood drawing and for processing samples are described.

89 e influence of factors such as the volume of blood drawn and the site of blood draw on the rates of b

90 rom the area under the curve (AUC) of serial blood draws and cumulative urinary excretion during a 24

91 d, 30 received interventions and 26 had >= 2 blood draws and depressive symptom assessments.

92 9.2 years) who had completed FACT-Cog v.3.0, blood draws and questionnaires.

93 These assessments included blood draws and self-report questionnaires assessing sym

94 Blood draws and self-reported depressive symptoms were c

95 existing approaches usually require invasive blood draws and/or bulky analytical laboratory equipment

96 f 35 patients with T1D (<6 mo after onset at blood draw) and 41 age-matched controls were assayed by

97 The difference between day 0 (<13 hours post-blood draw) and day 1 (24-37 hours) measurements was ana

98 two infant cohorts (N = 142 infants with 605 blood draws) and 40 y of infant dengue hospitalization d

99 ponse rates were 76.8% in the FCT (n = 1,505 blood draws) and 80.4% in Kano State (n = 2,178 blood dr

100 ing, prepregnancy weight, gestational age at blood draw, and child sex) with mean IQ were assessed by

101 cipants underwent cognitive testing, fasting blood draw, and FDG-PET at baseline.

102 by age, ethnicity, clinical center, time of blood draw, and follow-up duration.

103 by cohort, age, sex, race/ethnicity, date of blood draw, and follow-up time.

104 by age, ethnicity, clinical center, time of blood draw, and follow-up time.

105 r Los Angeles), birth year, date and time of blood draw, and hours fasting before blood draw.

106 by age, ethnicity, clinical center, time of blood draw, and length of follow-up.

107 sion, adjusting for maternal race, season of blood draw, and other potential confounders.

108 ntrols matched on date of blood draw, age at blood draw, and region was used to determine concentrati

109 cted in a 2:1 ratio matched for age, date of blood draw, and smoking status (n = 532).

110 pies/mL) completed a cognitive test battery, blood draw, and whole-blood immunophenotyping.

111 spective of symptoms, participated in annual blood draws, and completed periodic surveys, which inclu

112 g based on simultaneous intravenous sensing, blood draws, and intraarterial sensing, we found that in

113 self to real-time monitoring of gaps between blood draws, and the model may help users determine when

114 in a phase II MV trial during the period of blood draws, and were selected for this study in a blind

115 r; had a concurrent amyloid PET, tau PET and blood draw; and met clinical criteria for cognitively un

116 nts had clinical evaluations, brain MRI, and blood draws annually.

117 ective care; however, current methods (e.g., blood draws) are inconvenient and unpleasant.

118 Carboxyhemoglobin was measured in whole blood drawn around 13 weeks' gestation.

119 drinking water contamination using a venous blood draw as well as participant self-collection using

120 Participants completed a blood draw at baseline and annual cognitive evaluations.

121 ) completed a neuropsychological battery and blood draw at both waves.

122 2,075 indicated active HT use at the time of blood draw at study initiation and 15,661 did not.

123 elling antecubital venous cannula placed for blood drawn at baseline, 60, 120, and 180 minutes after

124 the Wallach Memory Recognition Test and had blood drawn at half-hour intervals over the course of an

125 rum n-3 PUFA concentrations were measured in blood drawn at inclusion using a nuclear magnetic resona

126 ticipants (age 53+/-8 years, 63% women) with blood drawn at rest (n=471) and at peak exercise (n=411)

127 violation by having missed blood samples or blood drawn at unscheduled times (group 2).

128 sk of type 1 diabetes in a birth cohort with blood draws at ages 9, 15, and 24 months and yearly ther

129 The method requires that a blood draw be made at a predetermined time after vaccina

130 r ex vivo stimulation with LPS compared with blood drawn before the start of the infusion, and (b) 17

131 atal bacteremia; one isolate (S613) was from blood drawn before treatment and the other isolate (R712

132 CTCs from 7.5 mL of whole blood drawn before treatment initiation (baseline) and m

133 icity and reactogenicity sub-study will have blood drawn before vaccination and at 2 timepoints after

134 ising 6 study periods, during which they had blood draws before and after medication administration.

135 of the critical or severe cases had "early" blood draws (before ICU admission; n = 33).

136 cruited at four sites for a research MRI and blood draw between February 2018 and October 2019.

137 physical activity questionnaires, had their blood drawn, body composition, cardiorespiratory fitness

138 After adjustment for month of blood draw, breast cancer status, colorectal cancer stat

139 l number did not change within 24 hours post-blood draw, but CD4 expression decreased 2.0+/-2.8% (P<0

140 ing method is less invasive than "classical" blood drawing, can be performed conveniently at home, an

141 l participants underwent 3 lumbar punctures, blood draw, clinical assessment of strength, motor funct

142 single-cell multiomics analyses from serial blood draws collected during the first week after clinic

143 all levels of disease severity, from serial blood draws collected during the first week of infection

144 genes in 100% of parental exomes from fresh blood draw, compared with only 82% of autopsy-sourced SD

145 absence of a contact system inhibitor during blood draw, contact activation of FXI can mistakenly app

146 ched to cases by cohort, age, sex, race, and blood draw date.

147 583 controls on cohort (sex), age, race, and blood draw date/time.

148 Patient characteristics at the time of blood draw did not predict persistence other than having

149 HCII-CLIP levels, independent of sex, age at blood draw, disease duration, and diagnosis age, were si

150 Furthermore, we derived a single blood draw dual-biomarker strategy combining hs-cTn and

151 The single blood draw dual-biomarker strategy is particularly attra

152 A lower vitamin D was associated with the blood draw during fall/winter months (P < .001), older a

153 ; subjects who selected plasma testing had a blood draw during the office visit.

154 cid composition were determined from fasting blood drawn during the final 4 d of each 3-wk diet perio

155 106 (with smokers in the satiated state) and blood draws during PET scanning to determine TSPO affini

156 Following the baseline blood draw, each subject was randomized to receive eithe

157 n of systemic corticosteroids at the time of blood draw for microarray analysis were classified in th

158 e change in BMI between 2002 and the time of blood draw for TCDD measurement (adjusted OR, 2.37; 95%

159 All blood drawn for culture from adult inpatients and emerge

160 and lifestyle, were examined physically, had blood drawn for DNA extraction, were tested for presence

161 male) underwent clinical assessment and had blood drawn for genotyping and methylation analysis.

162 rual cycle (primary outcome measure) and had blood drawn for gonadal hormone and neurosteroid levels

163 itizens responded to a questionnaire and had blood drawn for HIV testing in the absence of documentat

164 ldren 18 months to 19.9 years of age who had blood drawn for medical indications during an outpatient

165 o HIV, which can be performed using leftover blood drawn for routine CD4 cell count testing.

166 These subjects also had fasting blood drawn for serum cholesterol, glucose, and a number

167 All participants had fasting blood drawn for targeted lipidomics and underwent a Fibr

168 it, controlled light intensity, and repeated blood draws for assessment of analytes.

169 The order of blood draws for biochemistry and blood cultures was rand

170 ing safety and reactogenicity assessments or blood draws for immunogenicity assessments were masked.

171 Blood draws for the detection of insulin autoantibody, g

172 protein 3 in 6,520 women aged 32-70 years at blood draw from the Nurses' Health Study (1990-2006) and

173 ons to be expanded up to 500-fold in a 60-mL blood draw from the same donor.

174 PCR test results for HIV DNA on venous blood drawn from children ages 0-2 days and 3-5 months w

175 In experiments with fresh blood drawn from filaria-infected patients, we found no

176 on in human disease, the assay was tested on blood drawn from macaques infected with F. tularensis Sc

177 preparation was obtained from 10 ml of whole blood drawn from one age-matched donor rat.

178 n on circulating EV obtained from peripheral blood drawn from patients with IPMNs.

179 ients with MS were significantly elevated in blood drawn from the internal jugular vein and a periphe

180 who showed no exudative signs on the day of blood drawing had a cytokine profile that was similar to

181 eline and 3 months, participants had fasting blood drawn, had blood pressure measured, and wore thigh

182 ates were body mass index, winter and spring blood draw, history of diabetes, sedentary behavior, smo

183 metriosis risk among women aged <40 years at blood draw (IGF-1: IRR = 1.60, 95% CI: 0.86, 2.98; IGFBP

184 in 1,095 women who were free of diabetes at blood draw in 1989-1990 and participated in two case-con

185 cancer, and diabetes mellitus at the time of blood drawing in 1990.

186 CD64 indices were performed with peripheral blood drawn in tandem with blood cultures from 109 patie

187 and neurotrophins was observed in peripheral blood drawn in the first days of life.

188 re was complete concordance between 60 ml of blood drawn in the first two sets of 30 ml and three 20-

189 cal value and reduce the risk of unnecessary blood draws in children.

190 asting endothelial function measurements and blood draws in the morning after PSG.

191 atically tested remnant samples from routine blood draws in two major hospital networks in San Franci

192 lated from the same patient on two different blood draws, indicating persistence of this T-cell clone

193 In 15 who agreed to blood draw, inflammation and fibrosis markers were obtai

194 Conclusion Blood pressure readings, blood draws, injections, and number or duration of fligh

195 measurement, patients reported the number of blood draws, injections, blood pressure measurements, tr

196 is increases risk of lymphedema, ipsilateral blood draws, injections, blood pressure readings, and ai

197 ssessment survey that reported the number of blood draws, injections, blood pressure readings, trauma

198 y was to investigate the association between blood draws, injections, blood pressure readings, trauma

199 he model may help users determine when a new blood draw is required and delay blood draws when not ne

200 sting age, smoking, fasting status, month of blood draw, lipids, body mass index, and other cardiovas

201 d the baseline questionnaire, interview, and blood draw (lipopolysaccharide-stimulated production of

202 s and 1,066 age-, sex-, race-, and season-of blood draw-matched controls from 8 prospective cohort st

203 terviews) was defined as no trauma at either blood draw (n = 175), trauma at blood draw 1 but no PTSD

204 ex, clinic, year of enrollment, and month of blood draw (n=405).

205 found no significant variation attributed to blood draw number for the cfDNA or cfRNA.

206 f human somatic cells from skin biopsies and blood draws obtained from healthy donors.

207 Nine biomarkers were assayed from blood draws obtained on ED presentation.

208 ssociated with Alzheimer's disease even when blood draw occurred >5 years from death.

209 nation accuracy for Alzheimer's disease when blood draw occurred in years closer to death; however, h

210 a ctDNA genomic profiling, with biopsies and blood draws occurring within 30 days of one another.

211 as the volume of blood drawn and the site of blood draw on the rates of blood culture contamination.

212 Plasma was prepared from whole blood drawn on ICU admission in patients with influenza

213 mer's disease studies that included either a blood draw or a blood draw and lumbar puncture to explor

214 l model (environmental risk factors only, no blood draw or assays required) were created.

215 Viral load information was obtained via blood draw or medical record abstraction.

216 y 1994, 780 had confirmed type 2 diabetes at blood drawing or during follow-up to 1998 and were free

217 agnose and monitor mTBI without the need for blood draws or neuroimaging.

218 or level was associated within 6 years after blood draw (OR (</= 3 years), 95% CI, 1.4, 1.1-1.9, P =

219 ongest in those who were demented at time of blood draw (OR = 1.25, 95%CI = 1.02-1.53), but an effect

220 d change increase and undergoing one or more blood draws (P = .62), injections (P = .77), number of f

221 use, physical activity, alcohol intake, and blood draw parameters.

222 year 2006 were analyzed for their volume of blood drawn, patient's weight, site of blood draw used,

223 0.78, 0.98) or measurements from the second blood draw (per 10-ng/mL increase, odds ratio = 1.17, 95

224 RNA was measured by quantitative RT-PCR from blood drawn perioperatively in patients undergoing thyro

225 Even with optimal blood drawing, plasma TGF-beta1 was lower in mice render

226 blood draw study, and nearly half (48%) to a blood draw plus lumbar puncture study.

227 81% for the blood draw study and 70% for the blood draw plus lumbar puncture study.

228 aloxone delivery was verified by intravenous blood draw post-injection for all participants.

229 PRP was prepared from whole blood drawn prior to surgery and applied to root surface

230 during follow-up of more than 10 years after blood draw (quintile 5 vs. quintile 1: odds ratio = 2.55

231 After adjustment for age and date of blood draw, race, and body mass index, androgens were fo

232 0) diagnosed at least 5 years after baseline blood draw (range, 5-12 years; median 9 years) and frequ

233 s exposed to chemotherapy, with older age at blood draw (recurrent OC odds ratio [OR], 17.24; 95% CI,

234 sis according to age at diagnosis and age at blood draw revealed increased methylation levels in TNBC

235 nd 3,951 controls matched on age and year at blood draw, sex, race, and smoking status.

236 Blood draws showed normal clinical chemistry and hematol

237 also had TMA-positive results from the same blood draw; six were positive on repeat testing.

238 heral blood mononuclear cells collected at 8 blood draws spanning two 5-hour sessions (stress vs. no-

239 Blood-draw specimens (108) obtained at the same time fro

240 eway over their advance consent: 81% for the blood draw study and 70% for the blood draw plus lumbar

241 ) were willing to grant advance consent to a blood draw study, and nearly half (48%) to a blood draw

242 On day 1 after a fasting blood draw, subjects consumed 300 g yellow maize porridg

243 We derived serum from blood draws taken from 76 young and elderly subjects imm

244 and tumor dynamics through single or serial blood drawn tests.

245 er, ethnicity, and body mass index underwent blood draw the next morning for soluble CD40 ligand, asy

246 -hydroxyvitamin D concentration and month of blood draw, the highest values being during the summer m

247 the Ebola endpoint occurring from after the blood draw through to the end of follow-up, contrasting

248 ritically ill surgical patients, cultures of blood drawn through a catheter are less specific than th

249 Positive predictive value of cultures of blood drawn through a catheter is low and, when obtained

250 Culture of blood drawn through an indwelling central venous cathete

251 o a General Clinical Research Center and had blood drawn through an intravenous line for determinatio

252 zed hematology-oncology patients, culture of blood drawn through either the central catheter or perip

253 . brumae grew from a quantitative culture of blood drawn through the catheter.

254 l chemistry measures recorded during routine blood draws throughout the dolphins' lifetimes.

255 f follow-up) were matched by age and date of blood draw to 400 controls who were alive and free of ca

256 eward anticipation and outcome, and a venous blood draw to assess the inflammatory biomarkers interle

257 The median time from second blood draw to cancer diagnosis was 16 years; median foll

258 The median turnaround time from blood drawing to result notification was 13 days (Q1:9;

259 tinuous Performance Test (CPT) and had their blood drawn to assess endotoxemia markers LPS binding pr

260 The children had fasting blood drawn to quantify five inflammatory biomarkers-C-r

261 The children had fasting blood drawn to quantify five inflammatory biomarkers-C-r

262 ched by age, race, sex, and calendar date of blood draw (to control for seasonal variation).

263 ed during the first week of BCT and included blood draws, total body dual-energy x-ray absorptiometry

264 ong those diagnosed 10 years or longer after blood draw (upper tertile OR, 0.60; CI, 0.40-0.90), but

265 me of blood drawn, patient's weight, site of blood draw used, and blood culture results.

266 Platelet counts were measured within 4 h of blood draw using an automated cell counter.

267 ood pH and arterial CO(2) in between gaps of blood draws, using only readily available noninvasive da

268 ation, ethnicity, body mass index, season of blood draw, vascular risk, and apolipoprotein E4 genotyp

269 ), aged 8-50 years, completed IQ testing and blood draw via venipuncture to determine the relationshi

270 relates of 25(OH)D included male sex, summer blood draw, vigorous physical activity, vitamin D intake

271 The average age at first blood draw was 9.8 years (standard deviation, 1.9 years)

272 evated O(3) exposure up to one year prior to blood draw was associated with elevated immune markers r

273 CO exposure during the month of blood draw was estimated using a regression model contai

274 The median age and tacrolimus level at blood draw was not significantly different.

275 An additional blood draw was obtained in players that subsequently suf

276 A single blood draw was the only procedure categorized as minimal

277 A blood draw was used to assess IL-6 and create composite

278 of endocarditis-related bacteria from all 6 blood draws was 23%, 33%, and 60% for the toothbrushing,

279 Among 115 patients who underwent sequential blood draws, we evaluated the relationship between chang

280 f contamination among the different sites of blood draw were as follows: peripheral venipuncture, 36%

281 amin D or calcium supplements, and season of blood draw were considered as confounders.

282 o six air pollutants in the calendar year of blood draw were estimated.

283 and controls with matching age and month of blood draw were studied.

284 dioxide, and carbon monoxide in the year of blood draw were used.

285 PET/CT, whole-body probe counts, and blood drawing were performed over 8 d to assess pharmaco

286 Blood draws were conducted to monitor safety.

287 Plasma was collected from infants if venous blood draws were ordered by pediatricians.

288 Photoacoustic tomography and blood draws were performed at day 10 and then 24 h after

289 PET imaging, whole-body probe counts, and blood draws were performed to assess pharmacokinetics, b

290 PET imaging, whole-body probe counts, and blood draws were performed to assess the pharmacokinetic

291 s, among whom electrocardiograms and fasting blood draws were repeated at 3-year intervals from 1993

292 Fasting blood draws were used to quantify plasma inflammatory/me

293 control for chemotherapy exposure and age at blood draw when testing the association of somatic mosai

294 en were instructed to visit the clinic for a blood draw when the monitor indicated an LH surge.

295 when a new blood draw is required and delay blood draws when not needed.

296 However, the gold standard methods use a blood draw, which is painful and only offers discrete me

297 od collection, race/ethnicity, and timing of blood draw within the menstrual cycle.

298 Among patients with blood drawn within 30 minutes of injury, 212 patients (5

299 Among those with blood drawn within 60 minutes, 316 patients (56.1%) had

300 leted the primary vaccination series and had blood draws within the specified window at age 5 months,